Results 241 to 250 of about 2,608,517 (407)

Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities

open access: yesArthritis &Rheumatology, EarlyView.
Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley   +1 more source

Percutaneous Closure of a Diagonal Artery to Pulmonary Artery Fistula. [PDF]

open access: yesJACC Case Rep
Madanat L   +4 more
europepmc   +1 more source

Anatomic variability in coronary arterial distribution with regard to the arterial switch procedure [PDF]

open access: yes, 2002
Anderson, RH   +7 more
core   +1 more source

Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma.

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2013
S. Mussot   +7 more
semanticscholar   +1 more source

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

open access: yesArthritis &Rheumatology, EarlyView.
Objective Vacuoles E1 enzyme X‐linked autoinflammatory somatic syndrome (VEXAS) is a recently identified rare genetic disorder associated with somatic mutations in the UBA1 gene. VEXAS presents with a combination of inflammatory and hematologic manifestations, leading to increased morbidity and mortality.
Arsene M. Mekinian   +111 more
wiley   +1 more source

Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.

open access: yesAmerican Journal of Respiratory Cell and Molecular Biology, 2013
Amal Houssaini   +10 more
semanticscholar   +1 more source

Surgical Correction of Coarctation of the Main Pulmonary Artery [PDF]

open access: bronze, 1960
Wendell B. Thrower   +2 more
openalex   +1 more source

B cells and systemic sclerosis interstitial lung disease

open access: yesArthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman   +2 more
wiley   +1 more source

Surgical Treatment of Pulmonary Artery Angiosarcoma - A Ten-Year Experience. [PDF]

open access: yesBraz J Cardiovasc Surg
Edemskiy A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy